Seeing Is Believing
Currently out of the existing stock ratings of Graham Doyle, 5 are a SELL (23.81%), 11 are a HOLD (52.38%), 5 are a BUY (23.81%).
Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 40% that have a potential upside of 24.94% achieved within 115 days.
Graham Doyle’s has documented 36 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNN, Smith & Nephew SNATS at 05-Jun-2024.
Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 9/2/2022. The price target of $16.49 was fulfilled within 7 days with a profit of $1.5 (10.01%) receiving and performance score of 14.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$24.5
1 months 16 days ago
(06-Nov-2024)
8/9 (88.89%)
$-6.92 (-22.02%)
499
Hold
6 months 17 days ago
(05-Jun-2024)
0/3 (0%)
$-11.75 (-46.78%)
Buy
$15.29
$-9.37 (-38.00%)
$15.07
1 years 1 months 19 days ago
(03-Nov-2023)
3/14 (21.43%)
$-8.79 (-36.50%)
504
Buy
$33
$8.34 (33.82%)
$39.5
1 years 2 months 18 days ago
(04-Oct-2023)
0/2 (0%)
$9.53 (40.61%)
Buy
$16.94
$-7.72 (-31.31%)
$14.12
1 years 8 months 11 days ago
(11-Apr-2023)
0/3 (0%)
$-11.96 (-41.38%)
What Year was the first public recommendation made by Graham Doyle?